Proteomic analysis in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses

National Medical Journal of China

Volumn 88, Issue 12, 2008, Pages 858-860

  Xu, Gang ^a   Xiang, Cui Qin ^b   Lu, Ye ^b   Kang, Xiao Nan ^b   Wang, Wen Jing ^b   Liao, Ping ^b   Ding, Qiang ^b   Zhang, Yuan Fang ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Carcinoma, renal cell; Proteome; Serologic tests; Tomography, X ray computed

Indexed keywords

ADULT; ARTICLE; BENIGN TUMOR; BLOOD SAMPLING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DECISION TREE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PREOPERATIVE EVALUATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; BLOOD PROTEINS; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 44449119487     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Byvatov E, Schneider G. SVM-based feature selection for characterization of focused compound collections. J Chem Inf Comput Sci, 2004,44:993-999.
2. Tolson J, Bogumil R, Brunst E, et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest, 2004,84:845-856.
3. Chinese source.
4. Hara T, Honda K, Ono M, et al. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry. J Urol, 2005,174 (4Pt1):1213-1217.
5. Diamandis EP. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps. Cancer Res, 2006,66:5540-5541.
6. Engwegen JY, Gast MC, Schellens JH, et al. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci, 2006,27:251-259.
7. Silverman SG, Mortele KJ, Tuncali K, et al. Hyperattenuating renal masses: etiologies, pathogenesis, and imaging evaluation. Radiographics, 2007,27:1131-1143.
8. Remzi M, Katzenbeisser D, Waldert M, et al. Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int, 2007,99:1002-1006.